Venturi Wealth Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
CIM
RP
IHL
CPCPP
P
CNB
CCMINC
Venturi Wealth Management's CRL Position: Q2 2026 in Review
Venturi Wealth Management sold out of Charles River Laboratories (CRL) in Q2 2026, closing a stake of 1,557 shares — an estimated $269K sold.
Venturi Wealth Management first reported a position in CRL in Q1 2023 and held it in 12 quarters. The position peaked at $806K in Q4 2024. 81 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Venturi Wealth Management reported no remaining Charles River Laboratories position as of Q2 2026 after selling out during the quarter.
- Venturi Wealth Management sold 1,557 Charles River Laboratories shares in Q2 2026, an estimated $269K.
- Venturi Wealth Management first reported a position in Charles River Laboratories in Q1 2023 and held it in 12 quarters.
- Venturi Wealth Management's Charles River Laboratories position peaked at $806K in Q4 2024.
- 81 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Venturi Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.